4.8 Article

Catalytic oxidation of diclofenac by hydroxylamine-enhanced Cu nanoparticles and the efficient neutral heterogeneous-homogeneous reactive copper cycle

Journal

WATER RESEARCH
Volume 153, Issue -, Pages 274-283

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.watres.2019.01.024

Keywords

Cu nanoparticles; Neutral copper cycle; Molecule oxygen activation; Hydroxylamine; Fenton-like

Funding

  1. National Natural Science Foundation of China [21677055, 21407052]
  2. Fundamental Research Funds for the Central Universities, HUST [2017KFXKJC004, 2016YXMS287]

Ask authors/readers for more resources

This study has demonstrated that hydroxylamine (HA) could greatly enhance Cu nanoparticles (nCu) in activating molecular oxygen and significantly elevate the diclofenac (DCF) degradation rate about two orders of magnitude in neutral circumstances. Effects of several important parameters on the DCF degradation such as nCu loading, HA dosage, pH and reaction temperature were investigated in the nCu/HA/O-2 system. Multiple examinations revealed that the reactive Cu(III) species instead of OH center dot would be predominant in the nCu/HA/O-2 system, despite their similar DCF degradation pathways. Based on a HA-enhanced copper cycle depending on the pristine Cu-0@Cu(I) (hydro)oxides core-shell structure, the heterogeneous-homogeneous reaction mechanism was proposed. It included solid-liquid interfacial and bulk reactions, e.g. heterogeneous activation of O-2 by Cu(I) to produce H2O2 and homogeneous Cu(I)-catalytic generation of Cu(III) from H2O2. Further quantitative investigation of the main reactive species in the cycle revealed that the Cu(I) regeneration instead of the O-2 activation would be rate-limited. Besides, nCu could be recycled to effectively degrade DCF in four consecutive cycles in the raw neural nCu/HA/O-2 system. It suggested that the nCu/HA/O-2 system with a more efficient copper cycle would be a good alternative Fenton-like system in treating neutral recalcitrant organic wastewaters. (C) 2019 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available